OK Biotech Co., Ltd. (TPE:4155)

Taiwan · Delayed Price · Currency is TWD

15.15

+0.30 (2.02%)

Sep 18, 2026, 1:30 PM CST

Market Cap	2.08B -4.7%
Revenue (ttm)	1.54B -10.5%
Net Income	242.24M
EPS	1.67
Shares Out	137.17M
PE Ratio	9.06
Forward PE	n/a
Dividend	0.30 (1.98%)
Ex-Dividend Date	Oct 7, 2026

Volume	351,392
Open	14.85
Previous Close	14.85
Day's Range	14.85 - 15.15
52-Week Range	12.85 - 16.50
Beta	0.24
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About OK Biotech

OK Biotech Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of blood glucose monitoring systems and homecare healthcare devices in Taiwan, the rest of Asia, America, Africa, and Europe. The company offers nebulizers, blood glucose meters, glucometers, blood sugar meters, and blood glucose test strips. It also provides OTC hearing aids, multi-frequency therapy devices, and factory setup solutions, as well as professional OEM/ODM customized services. The company sells its products under the OK... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2004

Country Taiwan

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 4155

Full Company Profile

Financial Performance

In 2025, OK Biotech's revenue was 1.56 billion, a decrease of -6.81% compared to the previous year's 1.67 billion. Earnings were 82.45 million, a decrease of -12.26%.

Financial Statements